Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Enferm. clín. (Ed. impr.) ; 30(2): 108-113, mar.-abr. 2020. tab
Artigo em Espanhol | IBECS-Express | ID: ibc-FGT-3073

RESUMO

Objetivo: Evaluar si el conocimiento de la enfermedad asmática puede ser un factor protector frente al riesgo de neumonía adquirida en la comunidad (NAC) en las personas con asma mayores de 18 años que reciben tratamiento inhalado. Método: Estudio observacional de casos y controles en población con asma. Se reclutaron 123 personas con asma diagnosticadas de neumonía por criterios clínicos y radiológicos (casos) y 246 personas con asma no diagnosticados de neumonía durante el último año (controles), apareados por edad. El principal factor de estudio fue la valoración del conocimiento sobre la enfermedad asmática mediante un cuestionario ad hoc, de 7 preguntas con 2 posibles respuestas (conoce, no conoce). Resultados: El análisis bivariado muestra que el conocimiento de la enfermedad asmática tiene una asociación estadísticamente significativa como factor protector de NAC. En el análisis multivariante muestra una asociación del conocimiento de la enfermedad asmática como factor protector de NAC (OR = 0,24), independientemente de la edad, nivel de estudios, funcionalidad y gravedad del asma. Conclusiones: Un buen conocimiento de la enfermedad asmática permite reducir el riesgo de NAC en pacientes asmáticos con tratamiento inhalado


Objective: To assess whether knowledge of asthmatic disease may be a protective factor against the risk of community-acquired pneumonia (CAP) in people with asthma over the age of 18 who receive inhaled treatment. Method: observational study of cases and controls in a population with asthma. One hundred and twenty-three people with asthma diagnosed with pneumonia were recruited according to clinical and radiological criteria (cases), and 246 people with asthma not diagnosed with pneumonia during the past year (controls), matched by age. The main study factor was the assessment of knowledge about asthmatic disease through an ad hoc questionnaire, with seven questions and two possible answers (known, unknown). Results: the bivariate analysis shows that knowledge of asthmatic disease has a statistically significant association as a protective factor of CAP. In the multivariate analysis, it shows an association of knowledge of asthmatic disease as a protective factor of CAP (OR=.24), regardless of age, level of studies, functionality, and severity of asthma. Conclusions: A good knowledge of asthmatic disease reduces the risk of CAP in asthmatic patients using inhaled treatment

3.
Med. clín (Ed. impr.) ; 150(12): 455-459, jun. 2018. tab
Artigo em Espanhol | IBECS | ID: ibc-173646

RESUMO

Introducción y objetivo: El asma es una enfermedad crónica que precisa tratamiento inhalado y que, a su vez, es factor de riesgo (FR) de neumonía. En la cavidad orofaríngea existen numerosas especies de bacterias que podrían ser arrastradas a nivel broncoalveolar. Objetivo: determinar si la salud bucodental es un FR de neumonía adquirida en la comunidad (NAC) en pacientes asmáticos que realizan tratamiento inhalado y determinar si la frecuencia de utilización de los dispositivos de inhalación y el tipo de fármaco inhalado son FR de NAC. Pacientes y método: Estudio de casos y controles en población asmática con tratamiento inhalado. Se seleccionaron 126 pacientes asmáticos diagnosticados de neumonía por criterios clínicos y radiológicos (casos) y 252 asmáticos no diagnosticados de neumonía durante el último año (controles), emparejados por edad. El principal factor de estudio fue la puntuación del General Oral Health Assessment Index (GOHAI). Resultados: El análisis bivariado muestra una asociación estadísticamente significativa de la NAC con un índice de GOHAI≤57 puntos (mala salud bucodental) (OR 1,69), el tratamiento anticolinérgico (OR 2,41), realizar 6 o más inhalaciones al día (OR 3,23), el uso de cámara (OR 1,62), el FEV1 (OR 0,98), una alteración de la funcionalidad (OR 2,08) y los trastornos psiquiátricos o la depresión (OR 0,41). El análisis multivariante muestra una asociación independiente de realizar 6 o más inhalaciones al día (OR 2,74) y de las alteraciones de la funcionalidad (OR 1,67). Conclusiones: Los resultados evidencian que una mala salud bucodental podría ser un FR de NAC


Introduction and objective: Asthma is a chronic disease requiring inhaled treatment and in addition it is a risk factor (RF) of pneumonia. In the oropharyngeal cavity there are numerous species of bacteria that could be dragged to the bronco-alveolar level. Objective: to decide whether oral health is a community acquired pneumonia (CAP) RF in asthmatic patients who are taking inhaled treatment, and determining whether the frequency of use of inhalation devices and the type of inhaled drug are CAP RF. Patients and method: Case-control study in asthmatic population with inhaled treatment. We recruited 126 asthmatic patients diagnosed with pneumonia by clinical and radiological criteria (cases) and 252 asthmatics not diagnosed with pneumonia during the last year (controls), matched by age. The main factor of study was the General Oral Health Assessment Index (GOHAI) score. Results: Bivariated analysis showed a statistically significant association of CAP with a GOHAI score≤57 points (poor oral health) (OR 1.69), anticholinergic treatment (OR 2.41), 6 or more inhalations (3.23), chamber use (OR 1.62), FEV1 (OR 0.98), altered functionality (OR 2.08) and psychiatric disorders or depression (OR 0.41). The multivariated analysis shows an independent association of performing 6 or more inhalations per day (OR 2.74) and functional impairment (OR 1.67). Conclusions: The results suggest that poor oral health may be a CAP RF


Assuntos
Humanos , Masculino , Feminino , Higiene Bucal/efeitos adversos , Pneumonia Bacteriana/etiologia , Asma/complicações , Estudos de Casos e Controles , Fatores de Risco , Administração por Inalação , Nebulizadores e Vaporizadores , Infecções Comunitárias Adquiridas
4.
Med Clin (Barc) ; 150(12): 455-459, 2018 06 22.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-28947297

RESUMO

INTRODUCTION AND OBJECTIVE: Asthma is a chronic disease requiring inhaled treatment and in addition it is a risk factor (RF) of pneumonia. In the oropharyngeal cavity there are numerous species of bacteria that could be dragged to the bronco-alveolar level. OBJECTIVE: to decide whether oral health is a community acquired pneumonia (CAP) RF in asthmatic patients who are taking inhaled treatment, and determining whether the frequency of use of inhalation devices and the type of inhaled drug are CAP RF. PATIENTS AND METHOD: Case-control study in asthmatic population with inhaled treatment. We recruited 126 asthmatic patients diagnosed with pneumonia by clinical and radiological criteria (cases) and 252 asthmatics not diagnosed with pneumonia during the last year (controls), matched by age. The main factor of study was the General Oral Health Assessment Index (GOHAI) score. RESULTS: Bivariated analysis showed a statistically significant association of CAP with a GOHAI score≤57 points (poor oral health) (OR 1.69), anticholinergic treatment (OR 2.41), 6 or more inhalations (3.23), chamber use (OR 1.62), FEV1 (OR 0.98), altered functionality (OR 2.08) and psychiatric disorders or depression (OR 0.41). The multivariated analysis shows an independent association of performing 6 or more inhalations per day (OR 2.74) and functional impairment (OR 1.67). CONCLUSIONS: The results suggest that poor oral health may be a CAP RF.


Assuntos
Antiasmáticos/uso terapêutico , Asma/tratamento farmacológico , Infecções Comunitárias Adquiridas/etiologia , Saúde Bucal , Pneumonia/etiologia , Administração por Inalação , Idoso , Antiasmáticos/administração & dosagem , Asma/complicações , Asma/fisiopatologia , Estudos de Casos e Controles , Infecções Comunitárias Adquiridas/epidemiologia , Inquéritos de Saúde Bucal , Placa Dentária/microbiologia , Suscetibilidade a Doenças , Relação Dose-Resposta a Droga , Feminino , Volume Expiratório Forçado , Humanos , Masculino , Pessoa de Meia-Idade , Boca/microbiologia , Nebulizadores e Vaporizadores/estatística & dados numéricos , Pneumonia/epidemiologia , Prevalência , Utilização de Procedimentos e Técnicas , Risco , Fatores Socioeconômicos
5.
Enferm Clin ; 2018 Dec 29.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-30600151

RESUMO

OBJECTIVE: To assess whether knowledge of asthmatic disease may be a protective factor against the risk of community-acquired pneumonia (CAP) in people with asthma over the age of 18 who receive inhaled treatment. METHOD: observational study of cases and controls in a population with asthma. One hundred and twenty-three people with asthma diagnosed with pneumonia were recruited according to clinical and radiological criteria (cases), and 246 people with asthma not diagnosed with pneumonia during the past year (controls), matched by age. The main study factor was the assessment of knowledge about asthmatic disease through an ad hoc questionnaire, with seven questions and two possible answers (known, unknown). RESULTS: the bivariate analysis shows that knowledge of asthmatic disease has a statistically significant association as a protective factor of CAP. In the multivariate analysis, it shows an association of knowledge of asthmatic disease as a protective factor of CAP (OR=.24), regardless of age, level of studies, functionality, and severity of asthma. CONCLUSIONS: A good knowledge of asthmatic disease reduces the risk of CAP in asthmatic patients using inhaled treatment.

6.
Oncotarget ; 6(9): 7104-22, 2015 Mar 30.
Artigo em Inglês | MEDLINE | ID: mdl-25742793

RESUMO

There is an urgent need to refine the prognostic taxonomy of HER2+ breast carcinomas and develop easy-to-use, clinic-based prediction algorithms to distinguish between good- and poor- responders to trastuzumab-based therapy. Building on earlier studies suggesting that HER2+ tumors enriched with molecular and morpho-immunohistochemical features classically ascribed to basal-like tumors are highly aggressive and refractory to trastuzumab, we investigated the prognostic and predictive value of the basal-HER2+ phenotype in HER2-overexpressing tumors. Our retrospective cohort study of a consecutive series of 152 HER2+ primary invasive ductal breast carcinomas first confirmed the existence of a distinct subgroup co-expressing HER2 protein and basal cytokeratin markers CK5/6, the so-called basal-HER2+ phenotype. Basal-HER2+ phenotype (≥10% of cells showing positive CK5/6 staining), but not estrogen receptor status, was significantly associated with inferior overall survival by univariate analysis and predicted worsened disease free survival after accounting for strong prognostic variables such as tumor size at diagnosis in stepwise multivariate analysis. In the sub-cohort of HER2+ patients treated with trastuzumab-based adjuvant/neoadjuvant therapy, basal-HER2+ phenotype was found to be the sole independent prognostic marker for a significantly inferior time to treatment failure in multivariate analysis. A CK5/6-based immunohistochemical fingerprint may provide a simple, rapid, and accurate method for re-classifying women diagnosed with HER2+ breast cancer in a manner that can improve prognosis and therapeutic planning in patients with clinically aggressive basal-HER2+ tumors who are not likely to benefit from trastuzumab-based therapy.


Assuntos
Neoplasias da Mama/metabolismo , Carcinoma Ductal de Mama/metabolismo , Resistencia a Medicamentos Antineoplásicos , Queratina-5/metabolismo , Queratina-6/metabolismo , Receptor ErbB-2/metabolismo , Trastuzumab/química , Adulto , Idoso , Algoritmos , Neoplasias da Mama/tratamento farmacológico , Carcinoma Ductal de Mama/tratamento farmacológico , Intervalo Livre de Doença , Feminino , Humanos , Imunofenotipagem , Estimativa de Kaplan-Meier , Pessoa de Meia-Idade , Fenótipo , Valor Preditivo dos Testes , Prognóstico , Estudos Prospectivos , Estudos Retrospectivos , Resultado do Tratamento
7.
Sci Rep ; 4: 5743, 2014 Jul 18.
Artigo em Inglês | MEDLINE | ID: mdl-25034150

RESUMO

The one-step nucleic acid amplification (OSNA) assay is a molecular procedure that can identify deposits of breast cancer (BC) cells in the sentinel lymph node (SLN). We examined the consistency of the OSNA assay with a classic hematoxylin-eosin (H&E)-based immunohistochemistry (IHC) study and evaluated how OSNA-based axillary staging might impact the therapeutic management of BC patients. SLN biopsy results were considered to be positive in 60 patients (40%) in the OSNA group (N = 148) and in 43 (28%) patients in the IHC cohort (N = 153, p = 0.023). There was no difference in the macrometastasis (22% for OSNA, 15% for H&E, p = 0.139) or micrometastasis (19% for OSNA, 13% for H&E, p = 0.166) rates, but we found statistically significant differences in the number of isolated tumor cells (1% for OSNA, 11% for H&E, p < 0.001). There were no differences in the administration rate of adjuvant systemic therapy between the OSNA (66% in the SLN(+) patients) and the H&E (74% in the SLN(+) patients) groups (p = 0.159). The OSNA assay allows for the detection of SLN metastases more precisely than conventional pathologic methods but does not alter the therapeutic management of SLN(+) BC patients.


Assuntos
Neoplasias da Mama/patologia , Carcinoma Ductal de Mama/secundário , Linfonodos/patologia , Adulto , Idoso , Axila , Neoplasias da Mama/tratamento farmacológico , Neoplasias da Mama/genética , Carcinoma Ductal de Mama/tratamento farmacológico , Carcinoma Ductal de Mama/genética , Quimioterapia Adjuvante , Feminino , Humanos , Metástase Linfática , Pessoa de Meia-Idade , Técnicas de Diagnóstico Molecular , Estadiamento de Neoplasias/métodos , Técnicas de Amplificação de Ácido Nucleico , Melhoria de Qualidade
8.
Inf. psiquiátr ; (212): 203-216, abr.-jun. 2013. tab
Artigo em Espanhol | IBECS | ID: ibc-112436

RESUMO

La ansiedad es uno de los síntomas que aparece frecuentemente en los pacientes con demencia, si bien su prevalencia varía en función del tipo y fase de la misma, del sexo del individuo e incluso del grado de autonomía funcional. La ansiedad suele tener una repercusión importante sobre la calidad de vida del enfermo y sus cuidadores, lo que justifica la instauración de medidas no farmacológicas y a menudo, también farmacológicas. Ahora bien, la utilización de medicamentos en la población geriátrica y particularmente en los dementes es compleja, por la mayor sensibilidad a los fármacos y mayor susceptibilidad de padecer efectos no deseados. La instauración de tratamientos farmacológicos necesariamente conlleva a una revisión crítica y sistemática de su beneficio/riesgo de acuerdo a los objetivos terapéuticos que han sido predefinidos (AU)


Anxiety is a symptom that occurs frequently in patients with dementia, although their prevalence varies depending on the type and stage of it, the sex of the individual and even the degree of functional autonomy. Anxiety often has a significant impact on the quality of life of patients and their caregivers, which justifies the introduction of non-pharmacological measures and often also drugs. However, the use of drugs in the elderly, particularly in dementia is complex, because has a greater drug sensitivity and susceptibility to unwanted effects. The introduction of drug therapies necessarily leads a systematic critical review of the benefit/risk according therapeutic goals that have been predefined (AU)


Assuntos
Humanos , Masculino , Feminino , Idoso , Idoso de 80 Anos ou mais , Ansiedade/tratamento farmacológico , Idoso/psicologia , Avaliação Geriátrica/métodos , Demência/complicações , Psicotrópicos/uso terapêutico , Transtornos Mentais/epidemiologia , Doença de Alzheimer/complicações
9.
Oncol Lett ; 5(2): 459-462, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-23419985

RESUMO

Neuroendocrine tumors (NETs) are frequently associated with second primary malignancies (SPMs). Earlier studies have demonstrated that NETs are highly associated with synchronous or metachronous gastrointestinal and genitourinary SPMs. We report, for the first time, a case of pure NE breast carcinoma (NEBC) exhibiting all of the World Health Organization (WHO)-categorized morphological and phenotypic NE features (i.e., round solid nests of spindle cells, plasmacytoid cells, large clear or mucinous signet-ring cells with a peripheral palisading tendency and immunohistochemical positivity for the NE markers synaptophysin and chromogranin in more than 50% of the tumor cell population) along with synchronous abdominal non-Hodgkin's lymphoma. In the present study, we review the diagnosis, clinicopathological features and histogenetic profiling of NEBC and discuss the literature relevant to the clinical and anatomopathological management of this case. This previously unreported case of synchronous solid NEBC and abdominal lymphoma, together with earlier studies showing that primary symptoms are caused by SPMs in a significant subgroup of NET patients, strongly supports the notion that NETs should be cautiously considered to be index tumors. Therefore, risk-adapted clinicopathological follow-up with systematic investigation is strongly recommended.

11.
Mov Disord ; 23(8): 1130-6, 2008 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-18442107

RESUMO

Continuous subcutaneous apomorphine infusion (CSAI) is, at present, an alternative option for advanced Parkinson's disease (PD) with motor fluctuations. We studied the evolution of patients with PD and severe motor fluctuations long-term treated with CSAI. We reviewed data from 82 patients with PD (mean age, 67 +/- 11.07; disease duration, 14.39 +/- 5.7 years) and severe motor fluctuations referred to 35 tertiary hospitals in Spain. These patients were long-term treated (for at least 3 months) with CSAI and tolerated the procedure without serious side effects. We compared the baseline data of these 82 patients (before CSAI) with those obtained from the last follow-up visit of each patient. The mean follow-up of CSAI was 19.93 +/- 16.3 months. Mean daily dose of CSAI was 72.00 +/- 21.38 mg run over 14.05 +/- 1.81 hours. We found a statistically significant reduction in off-hours, according to self-scoring diaries (6.64 +/- 3.09 vs. 1.36 +/- 1.42 hours/day, P < 0.0001), total and motor UPDRS scores (P < 0.0001), dyskinesia severity (P < 0.0006), and equivalent dose of antiparkinsonian therapy (1,405 +/- 536.7 vs. 800.1 +/- 472.9 mg of levodopa equivalent units P < 0.0001). CSAI is an effective option for patients with PD and severe fluctuations, poorly controlled by conventional oral drug treatment.


Assuntos
Antiparkinsonianos/administração & dosagem , Apomorfina/administração & dosagem , Doença de Parkinson/tratamento farmacológico , Atividades Cotidianas/classificação , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Seguimentos , Marcha/efeitos dos fármacos , Humanos , Bombas de Infusão , Assistência de Longa Duração , Masculino , Pessoa de Meia-Idade , Atividade Motora/efeitos dos fármacos , Exame Neurológico/efeitos dos fármacos , Doença de Parkinson/diagnóstico , Resultado do Tratamento
14.
Med Clin (Barc) ; 122(9): 325-8, 2004 Mar 13.
Artigo em Espanhol | MEDLINE | ID: mdl-15033050

RESUMO

BACKGROUND AND OBJECTIVE: Parkinsonism is a group of neurological disorders characterized by extrapiramidal signs. Often, the differential diagnosis between parkinsonism, essential tremor and drug-induced parkinsonism is difficult. The aim of the study was to evaluate the utility of (123I)-FP-CIT SPECT in patients with movement disorders. PATIENTS AND METHOD: 52 patients were referred from the neurology department to characterize those with parkinsonism. Patients were clinically evaluated and those with Parkinson's disease were assessed using the rating scale Hoehn & Yahr and the UPDRS motor score. Subsequently, a (123I)-FP-CIT SPECT was performed with a qualitative analysis. RESULTS: All patients with essential tremor and drug-induced parkinsonism had a normal SPECT. All patients with parkinsonism displayed SPECT defects, except for four who had a normal SPECT result. Two of them were categorized as vascular parkinsonisms, one patient had a Shy-Drager's syndrome and the another one had probably a Parkinson's disease. The sensitivity and specificity were 90.47% (38/42; CI95%, 81.59%-99.35%) and 100% (10/10; CI95%, 69.15%-100%), respectively. CONCLUSIONS: (123I)-FP-CIT SPECT is an effective tool to study the integrity of the dopaminergic nigrostriatal system. Moreover, it permits to characterize the different types of parkinsonism.


Assuntos
Encéfalo/diagnóstico por imagem , Glicoproteínas de Membrana , Proteínas de Membrana Transportadoras , Proteínas do Tecido Nervoso , Doença de Parkinson/diagnóstico por imagem , Tomografia Computadorizada de Emissão de Fóton Único/métodos , Tropanos , Idoso , Gânglios da Base/diagnóstico por imagem , Gânglios da Base/metabolismo , Gânglios da Base/patologia , Proteínas de Transporte/metabolismo , Diagnóstico Diferencial , Proteínas da Membrana Plasmática de Transporte de Dopamina , Feminino , Humanos , Masculino , Proteínas de Membrana Transportadoras/metabolismo , Pessoa de Meia-Idade , Proteínas do Tecido Nervoso/metabolismo , Doença de Parkinson/metabolismo , Doença de Parkinson/patologia , Estudos Retrospectivos , Sensibilidade e Especificidade
15.
Med. clín (Ed. impr.) ; 122(9): 325-328, mar. 2004.
Artigo em Espanhol | IBECS | ID: ibc-30411

RESUMO

FUNDAMENTO Y OBJETIVO: Los parkinsonismos son un grupo de enfermedades neurológicas que se caracterizan por presentar una clínica extrapiramidal. A menudo, el diagnóstico diferencial entre los síndromes parkinsonianos, el temblor esencial y los parkinsonismos farmacológicos puede resultar difícil. El objetivo del estudio ha sido evaluar el rendimiento diagnóstico de la tomografía computarizada por emisión de fotón único (SPECT) en la caracterización de los trastornos del movimiento utilizando un trazador que se une a los transportadores presinápticos de la dopamina (123I-FPCIT). PACIENTES Y MÉTODO: Se incluyó a 52 pacientes, remitidos de la consulta de neurología con un síndrome parkinsoniano. Se realizó una evaluación clínica basada en la exploración neurológica a todos los pacientes y, en los pacientes con enfermedad de Parkinson, según los estadios de Hoehn & Yahr y la escala UPDRS. A todos los pacientes se les realizó una SPECT cerebral con 123 I-FP-CIT. La catalogación final de los pacientes se correlació con los resultados de la SPECT con 123 I-FP-CIT. RESULTADOS: Todos los pacientes con diagnóstico de temblor esencial y/o parkinsonismo farmacológico mostraron una SPECT normal. El resto de los pacientes diagnosticados de un síndrome parkinsoniano presentaron una SPECT alterada, en un grado variable, a excepción de 4 que tenían una SPECT normal y estaban diagnosticados de un parkinsonismo vascular (2 casos), síndrome de Shy-Drager (1 caso) y una probable enfermedad de Parkinson (1 caso). La sensibilidad fue del 90,47 por ciento (38/42; intervalo de confianza del 95 por ciento, 81,59-99,35 por ciento) y la especificidad del 100 por ciento (10/10; 69,15-100 por ciento). CONCLUSIONES: La SPECT con 123 I-FP-CIT es una herramienta útil para el estudio de la integridad del sistema dopaminérgico nigroestriado, que permite la caracterización de los diversos síndromes parkinsonianos (AU)


Assuntos
Pessoa de Meia-Idade , Masculino , Feminino , Idoso , Humanos , Glicoproteínas de Membrana , Proteínas de Membrana Transportadoras , Tropanos , Tomografia Computadorizada de Emissão de Fóton Único , Sensibilidade e Especificidade , Estudos Retrospectivos , Doença de Parkinson , Diagnóstico Diferencial , Proteínas de Transporte , Gânglios da Base , Proteínas do Tecido Nervoso , Telencéfalo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA